Commonly used substances for cardiac hypertrophy induction are ET-1 and phenylephrine (Foldes et al., 2011; Tanaka et al., 2014; Aggarwal et al., 2014; Deisl et al., 2019; Carlson et al., 2013). The gene discussed is EDN1; the disease is cardiac hypertrophy.